Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
Quarterly results
|
|
Edesa Biotech, Inc. (SBOT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/27/2023 |
10-K/A
| Annual Report for the period ended September 30, 2022 [amend] |
| 12/16/2022 |
10-K
| Annual Report for the period ended September 30, 2022 |
| 12/28/2021 |
10-K
| Annual Report for the period ended September 30, 2021 |
| 12/07/2020 |
10-K
| Annual Report for the period ended September 30, 2020 |
| 12/12/2019 |
10-KT
| Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]: |
| 11/30/2018 |
10-K
| Annual Report for the period ended September 30, 2018 |
| 12/01/2017 |
10-K
| Annual Report for the period ended September 30, 2017 |
| 12/14/2016 |
10-K
| Annual Report for the period ended September 30, 2016 |
| 12/14/2015 |
10-K
| Annual Report for the period ended September 30, 2015 |
| 09/09/2015 |
10-K/A
| Annual Report for the period ended August 31, 2014 [amend] |
| 11/21/2014 |
10-K/A
| Annual Report for the period ended August 31, 2014 [amend] |
| 11/14/2014 |
10-K
| Annual Report for the period ended August 31, 2014 |
|
|